The interventional cardiology market is expected to reach USD 31.47 Billion by 2021 from USD 21.83 Billion in 2016, at a CAGR of 7.1%. On the basis of type, the angioplasty stents market is segmented into drug-eluting stents, bare-metal stents, and bioabsorbable stents.
- Agency -.
Complete Report on Interventional Cardiology & Peripheral Vascular Devices Market spread across 190 Pages, Profiling 11 Companies and Supported with 150 Tables and 44 Figures is now available at www.rnrmarketresearch.com/interventional-cardiology-peripheral-vascular-devices-market-to-2016-embolic-protection-chronic-total-occlusion-coronary-atherectomy-thrombectomy-devices-ivus-angiography-catheters-evar-sten-market-report.html .
The drug-eluting stents segment is projected to witness the highest growth in this market due to increasing number of regulatory approvals and new product launches.
- Agency -.
Target Audience for this Report:
- Interventional cardiology and peripheral vascular devices manufacturers
- Interventional cardiology and peripheral vascular devices distributors
- Healthcare institutions (hospitals, medical schools, group practices, individual surgeons, and governing bodies)
- Various research and consulting companies
- Various research associations related to interventional cardiology and peripheral vascular devices
The global interventional cardiology and peripheral vascular devices market is segmented into angioplasty balloons, angioplasty stents, catheters, EVAR stent grafts, IVC filters, plaque modification devices, hemodynamic flow alteration devices, and accessories. Factors such as the aging population, rising incidence of cardiovascular diseases, increasing demand of minimally invasive procedures, and technological advancements are expected to drive the growth of this market.
Get Sample Report @
The drug-eluting stents segment is projected to witness the highest growth in this market due to increasing number of regulatory approvals and new product launches. On the basis of type, the catheters market is segmented into IVUS/OCT, angiography catheters, and guiding catheters.
In 2016, the IVUS/OCT segment is projected to witness the highest growth in this market due to increasing penetration rates and rapid advancements & innovations in these systems.
Company Profile (Business Overview, Products & Services, Key Insights, Recent Developments, SWOT Analysis, Ratio Analysis)
1 Medtronic PLC
2 Boston Scientific Corporation
3 Abbott Laboratories
4 Cordis Corporation (A Subsidiary of Johnson & Johnson Services, Inc.)
5 Accessclosure, Inc. (A Subsidiary of Cardinal Health, Inc.)
6 B. Braun Melsungen AG
7 Biosensors International Group Ltd.
8 C.R. Bard, Inc.
9 St. Jude Medical, Inc.
10 Terumo Corporation
The global interventional cardiology market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW).
Growth in the Asian region is primarily driven by the rising prevalence of cardiovascular diseases, increasing number of conferences & symposia, and increasing focus of major players on the Asian market.
Access report @ www.rnrmarketresearch.com/contacts/discount?rname=56915 .
Value Addition for the Buyer:
The global interventional cardiology market report aims to provide insights into. It provides valuable information on angioplasty balloons, angioplasty stents, catheters, EVAR stent grafts, IVC filters, plaque modification devices, hemodynamic flow alteration devices, and accessories.
Details on regional markets for these segments are also presented in this report.
Category: Market Research Publishers and RetailersCompany profile: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
For more information: